The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Tietz Textbook of Clinical Chemistry
(1999) · Archives of Pathology and Laboratory Medicine · doi:10.5858/123.7.646b · Cited by 2,495
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein
Sato, Y., Nakata, K., Kato, Y., Shima, M., Ishii, N., Koji, T., Taketa, K., Endo, Y., & Nagataki, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282502 · Cited by 439
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
Yuen, M.-F., Cheng, C.-C., Lauder, I. J., Lam, S.-K., Ooi, C. G., & Lai, C.-L. (2000) · Hepatology · doi:10.1002/hep.510310211 · Cited by 411
Oka, H., Tamori, A., Kuroki, T., Kobayashi, K., & Yamamoto, S. (1994) · Hepatology · doi:10.1002/hep.1840190111 · Cited by 370
Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein
&NA; (1994) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199412000-00009 · Cited by 356
α-fetoprotein: Reevaluation in hepatology
Taketa, K. (1990) · Hepatology · doi:10.1002/hep.1840120625 · Cited by 353
Taketa, K., Endo, Y., Sekiya, C., Tanikawa, K., Kōji, T., Taga, H., Satomura, S., Matsuura, S., Kawai, T., & Hirai, H. (1993) · PubMed · Cited by 297
Self-citation
Cited by
Biomarkers for the early diagnosis of hepatocellular carcinoma
Tsuchiya, N. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10573 · Cited by 569
Cell surface protein glycosylation in cancer
Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., & Packer, N. H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300387 · Cited by 518
Advances in the Early Diagnosis of Hepatocellular Carcinoma
Wang, W., & Wei, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.014 · Cited by 492
Hepatocellular carcinoma: From diagnosis to treatment
Grandhi, M. S., Kim, A. K., Ronnekleiv-Kelly, S. M., Kamel, I. R., Ghasebeh, M. A., & Pawlik, T. M. (2016) · Surgical Oncology · doi:10.1016/j.suronc.2016.03.002 · Cited by 456
Serum autoantibodies as biomarkers for early cancer detection
Tan, H. T., Low, J., Lim, S. G., & Chung, M. C. M. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07396.x · Cited by 315
Metadata
- Authors
- Li, D., Mallory, T., & Satomura, S.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 313
- Issue
- 1-2
- Pages
- 15-19
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2056746886
- Cited by
- 358
- References
- 19
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. https://app.cochat.ai/papers/10.1016/s0009-8981(01)00644-1
- The paper
- Li, D., Mallory, T., & Satomura, S. (2001). AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clinica Chimica Acta. https://doi.org/10.1016/s0009-8981(01)00644-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.